Following in the footsteps of blockbuster drugs such as Ozempic and Wegovy—both powered by semaglutide—Mounjaro (approved for ...

Mounjaro, an injectable medication designed to support weight loss, works by imitating the effects of two natural hormones, ...

The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...

The widely used anti-diabetes and weight loss drug Mounjaro, which contains the active ingredient tirzepatide, is now ...

People are buying healthier snacks and household food bills are dropping as GLP-1 weight-loss drugs alter eating habits.

Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.

The FBI has issued a warning about counterfeit versions of compounded weight loss drugs, which have been found to contain "unknown drugs, hig ...

The Nevada Division of Health Care Financing and Policy, which houses the state’s Medicaid program, estimated the proposed ...

The FDA wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies ...

Experts explain if Ozempic causes hair loss, and how the medication may indirectly lead to weight loss-related hair loss due ...

The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...